Over the last few years, this under-the-radar technology business has quietly become one of the largest companies in the FTSE ...

Drug developer GSK is vacating its 635,000-square-foot life sciences lab in Rockville, Maryland, where it was the sole tenant ...

Mike Ralston, CEO of Blencowe Resources (BRES) and Manuel Pablo Zúñiga-Pflücker, President and CEO of PetroTal (PTAL) will be presenting and taking live Q&A at focusIR's Investor Webinar on Tuesday ...

Today, the Natural History Museum, London, announced the first new permanent gallery to open since 2016, Fixing Our Broken Planet, which will open 3 April 2025. The gallery and a new programme of ...

Access to data and to skills specific to AI are among the key challenges pharma companies face to unlock the technology’s ...

The Department of Homeland Security is asking for the Internal Revenue Service to help crack down on immigration, according ...

The incoming employees at the biopharmaceutical giant will zero in on mRNA, structural biology, and viral vaccine research ...

GSK is moving out of its 635K SF footprint at 14200 Shady Grove Road, where it is the sole tenant, just before its lease ...

Other blue chips under pressure included Marks & Spencer, Barclays and Rolls-Royce, with their shares down by around 0.5%.

Deutsche Bank raises CMC Markets to 'hold' (sell) - price target 246 pence Barclays reinitiates Mulberry Group with 'equal weight' - price target 94 pence JPMorgan cuts Smurfit WestRock price target ...

The long-running HIV market rivalry between Gilead Sciences and GSK is about to turn a new page this year as Gilead looks to ...

GlaxoSmithKline "deliberately" discontinued a widely-used asthma medication in order to reap profits and families suffered, ...